Home › Cancro dei dotti biliari (Colangiocarcinoma) › New York › New York City
Studi clinici su Cancro dei dotti biliari (Colangiocarcinoma) a New York City, NY
11 studi su Cancro dei dotti biliari (Colangiocarcinoma) cercano partecipanti presso sedi a New York City e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study of PHST001 in Advanced Solid Tumors
In reclutamentoFase 1
- Mount Sinai, New York
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
In reclutamentoFase 3
- Memorial Sloan Kettering Cancer Center (Site 108), New York
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
In reclutamentoFase 1
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
In reclutamentoFase 3
- Memorial Sloan Kettering Cancer Centers, New York
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
In reclutamentoFase 1/2
- New York University Langone Health, New York
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
In reclutamentoFase 2
- Memorial Sloan Kettering Cancer Center, New York
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
In reclutamentoFase 4
- New York Presbyterian Hospital-Columbia University Medical Center, New York
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
In reclutamentoFase 2
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of MGC028 in Participants With Advanced Solid Tumors
In reclutamentoFase 1
- Icahn School of Medicine at Mt. Sinai, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, New York
The Dragon PLC Trial (DRAGON-PLC)
In reclutamento
- Memorial Sloan Kettering Cancer Center, New York
Studi su Cancro dei dotti biliari (Colangiocarcinoma) in altre città
- Houston, TX13 studi
- Boston, MA8 studi
- Rochester, MN7 studi
- Arlington, VA7 studi
- Los Angeles, CA7 studi
- Chicago, IL7 studi
- Columbus, OH6 studi
- Cleveland, OH6 studi
- Queens, NY5 studi
- Edison, NJ5 studi
- Nashville, TN5 studi
- Grand Rapids, MI5 studi
Altri studi a New York City
- Cancro al seno136 studi
- Cancro del polmone non a piccole cellule121 studi
- Cancro (tutti i tipi)109 studi
- Cancro alla prostata103 studi
- Cancro metastatico93 studi
- Cancro colorettale78 studi
- Cancro ovarico69 studi
- Cancro ai polmoni60 studi
- Mieloma multiplo60 studi
- Cancro pancreatico60 studi
- Cancro dell'endometrio52 studi
- Leucemia mieloide acuta51 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.